Evidence map›Paper›PMID 29494701›Full record

ArticlePLoS pathogens2018

Wicked: The untold story of ciprofloxacin.

Zachary C Conley, Truston J Bodine, Andrew Chou, Lynn Zechiedrich

Abstract read
In one paragraph

Article in PLoS pathogens, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed.

  1. Article
  2. Article
  3. Journal of bacteriology · 2024
    Article
  4. Epidemiological, Virulence, and Antibiotic Resistance Analysis ofAnimals : an open access journal from MDPI · 2024
    Article
  5. Article
  6. Article
  7. Article
  8. Fluoroquinolone-Based Organic Salts (GUMBOS) with Antibacterial Potential.International journal of molecular sciences · 2023
    Article
  9. Article
  10. The socio-economic challenges of managing pathogen evolution in agriculture.Philosophical transactions of the Royal Society of London. Series B, Biological sciences · 2023
    Review
  11. Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. Pandemic fluoroquinolone resistantProceedings of the National Academy of Sciences of the United States of America · 2019
    Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Zachary C ConleyVerna and Marrs McLean Department of Biochemistry and Molecular Biology, Baylor College of Medicine, Houston, Texas, United States of America.ORCID 0000-0001-9673-740X
Truston J BodineDepartment of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, Texas, United States of America.
Andrew ChouDepartment of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, Texas, United States of America.ORCID 0000-0002-3104-9451
Lynn ZechiedrichVerna and Marrs McLean Department of Biochemistry and Molecular Biology, Baylor College of Medicine, Houston, Texas, United States of America.ORCID 0000-0003-0533-1637

Funding

MEDICAL SCIENTIST TRAINING PROGRAMT32GM007330 · NIGMS · BAYLOR COLLEGE OF MEDICINE · PI PLON, SHARON E. · 1985 to 2019
$15.6M
Research Training in Infections and ImmunityT32AI055413 · NIAID · BAYLOR COLLEGE OF MEDICINE · PI GIORDANO, THOMAS P, MYSOREKAR, INDIRA U · 2003 to 2024
$3.2M
Training Program in Translational Biology and Molecular MedicineT32GM088129 · NIGMS · BAYLOR COLLEGE OF MEDICINE · PI ROONEY, CLIONA M., VAN DEN VEYVER, IGNATIA B · 2010 to 2019
$3.0M
Molecular Basis of Infectious Diseases Training GrantT32AI055449 · NIAID · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI LORENZ, MICHAEL C · 2005 to 2025
$2.6M
S2: Molecular Mechanisms Underlying Fluoroquinolone Susceptibility and ResistanceR01GM115501 · NIGMS · BAYLOR COLLEGE OF MEDICINE · PI ZECHIEDRICH, LYNN · 2015 to 2018
$1.7M
NIAID NIH HHS T32 AI055413NIAID NIH HHS T32 AI055449NIGMS NIH HHS R01 GM115501NIGMS NIH HHS T32 GM007330NIGMS NIH HHS T32 GM088129NIH HHS T32 AI55413NIH HHS T32 AI55449NIH HHS T32 GM007330NIH HHS T32 GM088129
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Drug Resistance, BacterialAnti-Bacterial AgentsBacteriaBacterial InfectionsCiprofloxacinHumansAnti-Bacterial AgentsCiprofloxacin

Identifiers

PMID29494701
PMCPMC5832386

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.